MedPath

Benifits of giving albumin in abdominal surgeries in newborns.

Not Applicable
Conditions
Health Condition 1: K00-K95- Diseases of the digestive system
Registration Number
CTRI/2020/09/027632
Lead Sponsor
PGIMER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. All neonates undergoing abdominal surgery(All GIT atresias, malrotation, gastroschisis, exomphalos minor, NEC, bowel perforations)

2. Gestation > 32 weeks

Exclusion Criteria

1. Acute kidney injury ( Serum creatinine > 1.5) or oliguria (urine output < 1 ml/kg/hr)

2. Ventilated neonates requiring Fio2 > 60%.

3. Congestive cardiac failure

4. CKD patients

5. Colostomy for anorectal malformations.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in surgical complication rate in neonates receiving albumin infusion as compared to the placebo group.Timepoint: Discharge/ Death
Secondary Outcome Measures
NameTimeMethod
1.Incidence of sepsis in both the groups <br/ ><br>2.Incidence of mortality in both the groups. <br/ ><br>3.Comparison of biochemical parameters- Blood urea nitrogen levels , serum creatinine, Serum albumin levels (g/l), Serum prealbumin and sodium between two groups. <br/ ><br>4.Comparison of ventilation days and inotrope requirement in both the groups. <br/ ><br>Timepoint: At discharge/ Death
© Copyright 2025. All Rights Reserved by MedPath